Karyopharm Therapeutics Stock Forecast - Price Action Indicator
| KPTI Stock | USD 1.13 0.04 3.42% |
Karyopharm Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Karyopharm Therapeutics stock prices and determine the direction of Karyopharm Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Karyopharm Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Karyopharm Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Karyopharm Therapeutics' systematic risk associated with finding meaningful patterns of Karyopharm Therapeutics fundamentals over time.
Check out Historical Fundamental Analysis of Karyopharm Therapeutics to cross-verify your projections. Karyopharm |
Open Interest Against 2024-05-17 Karyopharm Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Karyopharm Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Karyopharm Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Karyopharm Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Karyopharm Therapeutics' open interest, investors have to compare it to Karyopharm Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Karyopharm Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Karyopharm. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Karyopharm Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Karyopharm Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Karyopharm Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
Price Action indicator evaluates an asset for a given trading period using the following formula: ((close - open) + (close - high) + (close - low)) / 2. This indicator is consistent with the interpretation of Japanese candlestick patterns.| Previous Price Action Indicator | Price Action Indicator | Trend |
| (0.05) | (0.05) |
| Check Karyopharm Therapeutics Volatility | Backtest Karyopharm Therapeutics | Information Ratio |
Karyopharm Therapeutics Trading Date Momentum
| On April 23 2024 Karyopharm Therapeutics was traded for 1.13 at the closing time. The top price for the day was 1.20 and the lowest listed price was 1.12 . There was no trading activity during the period 0.0. Lack of trading volume on April 23, 2024 did not cause price change. The trading delta at closing time against the current closing price is 3.54% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Karyopharm Therapeutics to competition |
Other Forecasting Options for Karyopharm Therapeutics
For every potential investor in Karyopharm, whether a beginner or expert, Karyopharm Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Karyopharm Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Karyopharm. Basic forecasting techniques help filter out the noise by identifying Karyopharm Therapeutics' price trends.View Karyopharm Therapeutics Related Equities
| Risk & Return | Correlation |
Karyopharm Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Karyopharm Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Karyopharm Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Karyopharm Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Karyopharm Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Karyopharm Therapeutics shares will generate the highest return on investment. By undertsting and applying Karyopharm Therapeutics stock market strength indicators, traders can identify Karyopharm Therapeutics entry and exit signals to maximize returns.
Karyopharm Therapeutics Risk Indicators
The analysis of Karyopharm Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Karyopharm Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting karyopharm stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 6.57 | |||
| Semi Deviation | 5.93 | |||
| Standard Deviation | 8.78 | |||
| Variance | 77.16 | |||
| Downside Variance | 41.93 | |||
| Semi Variance | 35.19 | |||
| Expected Short fall | (8.78) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Karyopharm Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Karyopharm Therapeutics' short interest history, or implied volatility extrapolated from Karyopharm Therapeutics options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Karyopharm Therapeutics to cross-verify your projections. For more detail on how to invest in Karyopharm Stock please use our How to Invest in Karyopharm Therapeutics guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for Karyopharm Stock analysis
When running Karyopharm Therapeutics' price analysis, check to measure Karyopharm Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Karyopharm Therapeutics is operating at the current time. Most of Karyopharm Therapeutics' value examination focuses on studying past and present price action to predict the probability of Karyopharm Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Karyopharm Therapeutics' price. Additionally, you may evaluate how the addition of Karyopharm Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |
Is Karyopharm Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Karyopharm Therapeutics. If investors know Karyopharm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Karyopharm Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.25) | Revenue Per Share 1.279 | Quarterly Revenue Growth 0.005 | Return On Assets (0.27) | Return On Equity (8.91) |
The market value of Karyopharm Therapeutics is measured differently than its book value, which is the value of Karyopharm that is recorded on the company's balance sheet. Investors also form their own opinion of Karyopharm Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Karyopharm Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Karyopharm Therapeutics' market value can be influenced by many factors that don't directly affect Karyopharm Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Karyopharm Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Karyopharm Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Karyopharm Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.